-
Genetic Correlation of miR-423 Polymorphism rs8067576 with Progression and Prognosis of Triple-Negative Breast Cancer
-
LINC01128 Affects Triple-Negative Breast Cancer Progression Through Targeting miR-32-5p
-
Molecular and genomic advances in breast cancer: A comprehensive review of predictive and therapeutic innovations
-
Stem cell–mediated neuroplasticity and psychological recovery in cancer survivors: Mechanisms, evidence, and translational challenges
-
Novel Insights into the Oncogenic Role and Clinical Significance of ORC6L in Breast Cancer
-
Abemaciclib in HR+, HER2− Breast Cancer: A Narrative Review of the Clinical Evidence
-
HER2 Heterogeneity in Breast Cancer: Biological Basis, Clinical Implications, and Therapeutic Strategies
-
The Regulatory Mechanism and Value in Early Diagnosis and Prognosis Assessment of miR-4448 in Breast Cancer
-
Harnessing Gut Microbiota to Enhance Immunotherapy in NSCLC: From Mechanisms to Translational Applications
-
Capecitabine versus Paclitaxel After CDK4/6 Inhibitor Progression in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Real-World Study
-
Traditional Chinese Medicine for lung cancer: Mechanisms, clinical evidence, and future perspectives
-
When “CAM” is not CAM: Interpreting national cancer database analyses in breast cancer
-
PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model
-
Advances in the Treatment of Breast Cancer at Different Stages of Pregnancy
-
Molecular cancer prevention: Intercepting disease
-
Hematologic Glyco-Signatures: Emerging Blood-Based Sugar Codes Linked to Hyper-Aggressive Breast Cancer
-
Clinical Relevance of USP44 Expression and DNA Methylation Status in Breast Cancer Cell Lines, Tumor Tissues, and Circulating Tumor DNA
-
Clinical Efficacy and Security Analysis of CDK4/6 Inhibitors Combined with ET in Patients with HR+HER2− Advanced Breast Cancer
-
Integration of Raman Spectroscopy and Metabolomics for Early Breast Cancer Detection and Classification
-
Metabolic Fingerprinting of Urine Reveals Metabolite Changes in Women With Breast Cancer
-
Factors Associated With Alcohol Intake in Patients With Newly Diagnosed Breast Cancer
-
Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan
-
Efficacy of CDK4/6 Inhibitor Plus Aromatase Inhibitor versus Fulvestrant in Chinese Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer
-
Identification of Key Microbial Signatures Associated With Breast Cancer: Machine Learning‐Based Approaches Using Gut Microbiome Data
